Table 4.
IPA canonical pathways | P‐value | |
---|---|---|
Atherosclerosis signaling | 5.60 × 10−7 | |
Role of NANOG in mammalian embryonic stem cell pluripotencya | 2.53 × 10−6 | |
Role of osteoblasts, osteoclasts, and chondrocytes in rheumatoid arthritisb | 5.59 × 10−6 | |
Role of tissue factor in cancera | 1.41 × 10−5 | |
Natural killer cell signalinga | 1.53 × 10−5 |
IPA biological functions | P‐value | No. of genes associated |
---|---|---|
Diseases and disorders | ||
Connective tissue disorders | 2.86 × 10−13 | 77 |
Inflammatory disease | 2.86 × 10−13 | 91 |
Organismal injury and abnormalities | 2.86 × 10−13 | 348 |
Skeletal and muscular disordersb | 2.86 × 10−13 | 104 |
Cancera | 4.66 × 10−11 | 343 |
Molecular and cellular functions | ||
Cellular growth and proliferationa | 1.28 × 10−11 | 121 |
Cellular movementa | 1.70 × 10−10 | 80 |
Cellular Developmenta | 1.05 × 10−9 | 86 |
Cell‐to‐cell signaling and interactiona | 5.07 × 10−8 | 60 |
Cell death and survivala | 6.10 × 10−7 | 102 |
KEGG pathways | No. of genes associated | |
---|---|---|
Metabolic pathwaysa | 22 | |
MAPK signaling pathwaya | 17 | |
Pathways in cancera | 16 | |
Cytokine/cytokine receptor interactiona | 14 | |
PI3K‐Akt signaling pathwaya | 14 | |
Ras signaling pathwaya | 14 | |
Proteoglycans in cancera | 13 | |
Regulation of actin cytoskeletona | 12 | |
Rap1 signaling pathway | 12 | |
MicroRNAs in cancera | 11 |
IPA and KEGG analysis of the 301 upregulated and 60 downregulated genes identified to be targeted by the 29 deregulated miRNAs.
Association with cancer development and progression.
Association with bone cell biology.